OpenAlex
PricingAboutJobs
Log inGet started
Work

Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors

HTML

Year: 2018
Type: article
Study design: Case Report
Source: Melanoma Research
DOI: 10.1097/cmr.0000000000000458
Authors: Alexander Thiem, Patrick Schummer, Simon Ueberschaar, Andreas Kerstan, Hermann Kneitz, David Schrama, Silke Appenzeller, Svenja Meierjohann, Bastian Schilling, Matthias Goebeler, Anja Gesierich
Institutions: Comprehensive Cancer Center Mainfranken, Universitätsklinikum Würzburg, University of Würzburg
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: pembrolizumab, PD-1 inhibitors, melanuria, liver metastasis, immune-related adverse events, treatment response prediction, elderly patients, targeted therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2804959633
FWCI: 0.407
Cites: 14
Cited by: 8
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security